Tag Archives: Stock

Scotts Miracle-Gro Just Cut Its Outlook, but Its Share Price Soared

Scotts Miracle-Gro Just Cut Its Outlook, but Its Share Price Soared

Scotts Miracle-Gro Just Cut Its Outlook, but Its Share Price Soared

Though there are a number of direct players in the industry, some of the most surprising growth can be seen in emerging industry players. One such name is Scotts Miracle-Gro.

The Very First Cannabis Stock ETF Is Now in Bear-Market Territory

The Very First Cannabis Stock ETF is Now in Bear-Market Territory

The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.

Canadian Cannabis Stock Rises With Friday's Cultivation Announcement

Canadian Cannabis Stock Rises With Friday’s Cultivation Announcement

On May 19, 2017, Beleave Inc. (CNX:BE) announced that its subsidiary, First Access Medical Inc., had been awarded a cultivation license from Health Canada, prompting the Canadian cannabis stock to rise 7.62% on Friday.

leafbuyer

Leafbuyer Technologies, Inc. Announces Effectiveness of Forward Split

GREENWOOD VILLAGE, Colo., May 4, 2017 /Weed Wire/ — Leafbuyer Technologies, Inc. (OTC: LBUY) announced today the effectiveness of the 9.25 for 1 forward split of its common stock is upon the open of trading May 5th, 2017 and the stock will begin trading on a split-adjusted basis.

Marijuana Stocks Get Bounce After Dispensary Raids Throughout Canada

Marijuana Stocks Get Bounce After Dispensary Raids Throughout Canada

Publicly-traded marijuana companies had a rough week but got a bounce Thursday following news of raids at the Cannabis Culture dispensary chain owned by Marc and Jodie Emery.

Mentor Capital

Mentor Capital Acquires $1.0 Million of GW Pharmaceuticals, Plc

SAN DIEGO, Calif., March 3, 2017/Weed Wire/ — Mentor Capital, Inc. (OTCQB: MNTR) announced it has taken a $1.0 million position in the stock of GW Pharmaceuticals, Plc (NASDAQ: GWPH), a United Kingdom based group developing a portfolio of cannabinoid prescription medicines.

Aurora Cannabis Inc Remains a Top Cannabis Pick

Aurora Cannabis Inc Remains a Top Cannabis Pick

Investors are becoming more and more impressed with the job CEO Terry Booth and his team are doing at Aurora Cannabis Inc. After posting strong Q2 results and closing a C$75 million financing, there’s a lot to like with company.

Medical Marijuana Inc Fails To Delight Investors

Medical Marijuana Inc Fails to Delight Investors

In the last trading session, the stock price of Medical Marijuana Inc (OTCMKTS:MJNA) declined more than 8% to close the day at $0.112. The decline came at a share volume of 24.74 million compared to average share volume of 17.32 million.

Can This Marijuana Stock Add Some Green to Your Portfolio?

Can This Marijuana Stock Add Some Green to Your Portfolio?

Investors in cannabis companies had an eventful 2016 with the approval of recreational marijuana usage in the states of California, Massachusetts, Maine, and Nevada providing a boost to all sorts of marijuana stocks. Of particular note, shares of Corbus Pharmaceuticals (NASDAQ: CRBP) posted a whopping 600% gain in 2016 following positive phase 2 data.

Why these pot stocks smoked the ASX today

Why These Pot Stocks Smoked the ASX Today

It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.

Surna leadership reflector and Agrisoft Agreement and shares call results and board of directors and cloud 9 wholesale

Surna Inc. Converts $2.76 Million of Debt

BOULDER, Colo., Feb. 21, 2017 /Weed Wire/ — Surna Inc. (OTCQB: SRNA) converted $2.76 million of its 10% convertible promissory notes, consisting of approximately $2.28 million in principal and $480,000 of accrued interest, into approximately 18 million shares of newly issued common stock and cash payments of less than $200,000.

Can Aphria Inc. Challenge Canopy Growth Corp.’s Dope Dominance?

Can Aphria Inc. Challenge Canopy Growth Corp.’s Dope Dominance?

Canopy Growth Corp. has garnered the most attention and established itself as the market leader; however, there is another company in the Canadian marijuana industry that could emerge as a potential winner.

Canopy Growth Corp. Could Crash Over Use of Banned Pesticides

Canopy Growth Corp. Could Crash Over Use of Banned Pesticides

Canopy Growth’s recently acquired Mettrum Ltd. stated that it wrote off $800,000 of costs owing to a series of recalls over the use of a banned pesticides. The staff at Mettrum feared detection from authorities, so they hid the pesticides in the office’s ceiling tiles.

Millionaires are Being Made From Cashing in on This Cannabis Stock

Millionaires Are Being Made From Cashing in on This Pot Stock

Since seeing all the buzz and craze these companies are causing in the marketplace, we’ve been hot on the trail of companies tied to the cannabis sector. The budding marijuana industry has spawned several high flying stocks lately, like Mentor Capital Inc.

Top 5 States for Marijuana Stocks

Top 5 States for Marijuana Stocks

Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.

Should Investors Consider Canopy Growth Corp.?

Should Investors Consider Canopy Growth Corp.?

Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.

How Big Could the Opportunity Be for Marijuana Stocks in California?

How Big Could the Opportunity Be for Marijuana Stocks in California?

The market for marijuana is exploding as Americans overwhelmingly embrace legalization. Analysts are projecting tens of billions of dollars in future marijuana sales, making this an intriguing market for investors.

Zynerba

Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock

DEVON, Pa., Jan. 19, 2017 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced the pricing of an underwritten public offering of 2.8 million shares of its common stock at a price of $18.00 per share, with expected gross proceeds to Zynerba of $50.4 million.

The Fast Moves on MassRoots Inc(OTCMKTS:MSRT) as Pot Stock Sector Booms

The Fast Moves on MassRoots Inc as Pot Stock Sector Booms

MassRoots Inc(OTCMKTS:MSRT) describes itself as one of the largest technology platforms for the regulated cannabis industry. MSRT is at the right place at the right time as the pot sector has been seeing huge growth in recent months as medical MJ products in the U.S. alone are projected to generate up to $35 Billion by 2020.

Top Marijuana Stocks to Watch in 2017

Top Marijuana Stocks to Watch in 2017

Sales in the legal marijuana industry are skyrocketing, which is why Money Morning created a list of the top marijuana stocks to watch in 2017. But because marijuana is still illegal under federal law, and many of the marijuana stocks on the market are so volatile, this isn’t a list of recommendations. Rather, it’s a list of marijuana stocks they are watching closely in 2017.

Canadian marijuana stocks regain momentum after Christmas

Canadian Marijuana Stocks Regain Momentum After Christmas

In the last few months, the medical marijuana growers have dominated the trading activity on the TSX Venture in terms of dollar volume almost exclusively, belying a persistent interest from investors in Canada and the United States.

Vitality Biopharma: A Seriously Undervalued Cannabis Stock

Vitality Biopharma: A Seriously Undervalued Cannabis Stock

While many investors were drawn in by the myth that millions would be made by investing in the companies that purportedly planned to cultivate and sell medical and leisure based marijuana, they should have been focused on investing in companies that are intent on utilizing the plant’s cannabinoid properties, which are consistently demonstrating extraordinary benefit in treating a host of medical conditions.

MassRoots Users Funding Round and Crosses Half a Million Users and NASDAQ

MassRoots Enters into Definitive Agreement to Acquire Whaxy in Cash and Stock Deal

DENVER, Dec. 15, 2016 /Weed Wire/ — MassRoots, Inc. (OTCQB:MSRT), one of the leading technology platforms for the cannabis industry, is pleased to report it has entered into a definitive agreement to acquire DDDigtal Inc. d.b.a. “Whaxy” & Cannabuild for $100,000 cash and 2,926,830 million shares of MassRoots’ common stock.

Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock?

Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock?

The fed’s report was largely positive for the recreational marijuana industry when it was released Tuesday. Aurora Cannabis stock was one of the biggest pot stock beneficiaries of the announcement, but has since had a regression in share price.


Page 1 of 212
Top